Published in Diabet Med on December 01, 2008
Circulating anti-Hsp70 levels in nascent metabolic syndrome: the Casale Monferrato Study. Cell Stress Chaperones (2012) 0.78
Diabetic nephropathy, chronic kidney disease and metabolic syndrome in Type 2 diabetes: answers or more questions? Diabet Med (2008) 0.77
The Cluster of Abnormalities Related to Metabolic Syndrome Is Associated With Reduced Glomerular Filtration Rate and Raised Albuminuria in Patients With Type 2 Diabetes Mellitus. J Clin Med Res (2017) 0.75
The role of the kidneys in glucose homeostasis: a new path towards normalizing glycaemia. Diabetes Obes Metab (2012) 2.44
Hypoglycaemia risk with insulin degludec compared with insulin glargine in type 2 and type 1 diabetes: a pre-planned meta-analysis of phase 3 trials. Diabetes Obes Metab (2012) 2.23
Epigenetic regulation of PPARGC1A in human type 2 diabetic islets and effect on insulin secretion. Diabetologia (2008) 2.15
Maternal triglyceride levels and newborn weight in pregnant women with normal glucose tolerance. Diabet Med (2005) 2.10
Cost-effectiveness analysis of invasive and noninvasive tests in high risk patients treated with amiodarone after acute myocardial infarction. J Am Coll Cardiol (1998) 2.02
More on the effect of atorvastatin on plasma fibrinogen levels in primary hypercholesterolemia. Atherosclerosis (1999) 1.94
Serum haptoglobin: a novel marker of adiposity in humans. J Clin Endocrinol Metab (2004) 1.94
Obesity and insulin resistance in humans: a dose-response study. Metabolism (1990) 1.74
Functional and morphological alterations of mitochondria in pancreatic beta cells from type 2 diabetic patients. Diabetologia (2005) 1.71
A telemedicine support for diabetes management: the T-IDDM project. Comput Methods Programs Biomed (2002) 1.69
Elevated S100B levels do not correlate with the severity of encephalopathy during sepsis. Br J Anaesth (2007) 1.63
Type 2 diabetes mellitus worsens arterial stiffness in hypertensive patients through endothelial dysfunction. Diabetologia (2012) 1.63
Inhibition of mTOR pathway by everolimus cooperates with EGFR inhibitors in human tumours sensitive and resistant to anti-EGFR drugs. Br J Cancer (2008) 1.62
Gemfibrozil improves insulin sensitivity and flow-mediated vasodilatation in type 2 diabetic patients. Eur J Clin Invest (2001) 1.54
Relation of glucose tolerance to complications of pregnancy in nondiabetic women. N Engl J Med (1986) 1.49
Roles of glucose transport and glucose phosphorylation in muscle insulin resistance of NIDDM. Diabetes (1996) 1.46
In Type 1 diabetic patients with good glycaemic control, blood glucose variability is lower during continuous subcutaneous insulin infusion than during multiple daily injections with insulin glargine. Diabet Med (2008) 1.46
Identification and cloning of a granule autoantigen (carboxypeptidase-H) associated with type I diabetes. J Clin Endocrinol Metab (1991) 1.39
Fasting hyperglycaemia following trans-catheter arterial chemo-embolization for hepatocellular carcinoma in cirrhosis. Ital J Gastroenterol Hepatol (1997) 1.39
Intermediate metabolism in normal pregnancy and in gestational diabetes. Diabetes Metab Res Rev (2003) 1.37
Transmembrane glucose transport in skeletal muscle of patients with non-insulin-dependent diabetes. J Clin Invest (1993) 1.34
Restoration of early rise in plasma insulin levels improves the glucose tolerance of type 2 diabetic patients. Diabetes (1999) 1.28
Prevalence and risk factors for gestational diabetes assessed by universal screening. Diabetes Res Clin Pract (2003) 1.27
Microalbuminuria in type 1 diabetes: rates, risk factors and glycemic threshold. Kidney Int (2001) 1.26
Glucose tolerance is negatively associated with circulating progenitor cell levels. Diabetologia (2007) 1.21
Evaluation of metalloproteinase 2 and 9 levels and their inhibitors in diabetic and healthy subjects. Diabetes Metab (2007) 1.17
FIRI: fasting or false insulin resistance index? Lancet (1996) 1.13
Women show worse control of type 2 diabetes and cardiovascular disease risk factors than men: results from the MIND.IT Study Group of the Italian Society of Diabetology. Nutr Metab Cardiovasc Dis (2012) 1.12
Effect of sodium intake on blood pressure and albuminuria in Type 2 diabetic patients: the role of insulin resistance. Diabetologia (2003) 1.12
Effects of glucosamine infusion on insulin secretion and insulin action in humans. Diabetes (2000) 1.10
Role of tissue-specific blood flow and tissue recruitment in insulin-mediated glucose uptake of human skeletal muscle. Circulation (1998) 1.08
Dietary habits in type II diabetes mellitus: how is adherence to dietary recommendations? Eur J Clin Nutr (2007) 1.07
Earlier intervention in type 2 diabetes: the case for achieving early and sustained glycaemic control. Int J Clin Pract (2005) 1.06
Insulin resistance, lipid and fatty acid concentrations in 867 healthy Europeans. European Group for the Study of Insulin Resistance (EGIR). Eur J Clin Invest (2000) 1.05
Reducing insulin resistance with metformin: the evidence today. Diabetes Metab (2003) 1.05
C-reactive protein and metabolic syndrome in women with previous gestational diabetes. Diabetes Metab Res Rev (2007) 1.03
Effect of insulin degludec versus sitagliptin in patients with type 2 diabetes uncontrolled on oral antidiabetic agents. Diabetes Obes Metab (2013) 1.02
Rosiglitazone prevents the impairment of human islet function induced by fatty acids: evidence for a role of PPARgamma2 in the modulation of insulin secretion. Am J Physiol Endocrinol Metab (2003) 1.01
Protein kinase C activity is acutely regulated by plasma glucose concentration in human monocytes in vivo. Diabetes (1999) 1.00
Pancreas transplant alone has beneficial effects on retinopathy in type 1 diabetic patients. Diabetologia (2006) 1.00
Insulin-mediated glucose disposal in type I diabetes: evidence for insulin resistance. J Clin Endocrinol Metab (1983) 0.99
What does postprandial hyperglycaemia mean? Diabet Med (2004) 0.99
Insulin resistance in Cushing's syndrome. J Clin Endocrinol Metab (1983) 0.98
Unresectable hepatocellular carcinoma in cirrhosis: survival, prognostic factors, and unexpected side effects after transcatheter arterial chemoembolization. Dig Dis Sci (1996) 0.98
Meiotic spindle presence and oocyte morphology do not predict clinical ICSI outcomes: a study of 967 transferred embryos. Reprod Biomed Online (2006) 0.98
Non-diabetic microalbuminuria, endothelial dysfunction and cardiovascular disease. Vasc Med (2001) 0.97
Intracellular lactate- and pyruvate-interconversion rates are increased in muscle tissue of non-insulin-dependent diabetic individuals. J Clin Invest (1996) 0.97
Brain function rescue effect of lactate following hypoglycaemia is not an adaptation process in both normal and type I diabetic subjects. Diabetologia (2000) 0.97
Beta-cell apoptosis in type 2 diabetes: quantitative and functional consequences. Diabetes Metab (2008) 0.96
Insulin resistance and diabetes mellitus. J Diabetes Complications (1997) 0.96
Effect of obesity and insulin resistance on resting and glucose-induced thermogenesis in man. EGIR (European Group for the Study of Insulin Resistance). Int J Obes Relat Metab Disord (1999) 0.96
Histone modification in early and late Drosophila embryos. Biochem J (1984) 0.95
Microalbuminuria and pulse pressure in hypertensive and atherosclerotic men. Hypertension (2000) 0.95
Secondary and tertiary structural differences between histone H1 molecules from calf thymus and sea-urchin (Sphaerechinus granularis) sperm. Biochem J (1981) 0.94
Molecular cloning of the gene encoding the bovine brain ribonuclease and its expression in different regions of the brain. Nucleic Acids Res (1991) 0.93
Pathological findings in subsynovial connective tissue in idiopathic carpal tunnel syndrome. Clin Neuropathol (2009) 0.93
Total body fat content and fat topography are associated differently with in vivo glucose metabolism in nonobese and obese nondiabetic women. Diabetes (1992) 0.92
The clinical reality of guidelines for primary prevention of cardiovascular disease in type 2 diabetes in Italy. Atherosclerosis (2008) 0.92
Postprandial hyperglycemia is a determinant of platelet activation in early type 2 diabetes mellitus. J Thromb Haemost (2010) 0.92
Biochemical and ultrasound tests for early diagnosis of active neuro-osteoarthropathy (NOA) of the diabetic foot. Diabetes Res Clin Pract (2002) 0.91
Expression of ADP-ribosyltransferase on normal T lymphocytes and effects of nicotinamide adenine dinucleotide on their function. J Immunol (1998) 0.90
Effect of metformin on insulin-stimulated glucose turnover and insulin binding to receptors in type II diabetes. Diabetes Care (1987) 0.90
Gliclazide protects human islet beta-cells from apoptosis induced by intermittent high glucose. Diabetes Metab Res Rev (2007) 0.90
G-protein-coupled receptor 40 (GPR40) expression and its regulation in human pancreatic islets: the role of type 2 diabetes and fatty acids. Nutr Metab Cardiovasc Dis (2009) 0.90
Insulin degludec improves long-term glycaemic control similarly to insulin glargine but with fewer hypoglycaemic episodes in patients with advanced type 2 diabetes on basal-bolus insulin therapy. Diabetes Obes Metab (2014) 0.89
Durability of glycaemic efficacy over 2 years with dapagliflozin versus glipizide as add-on therapies in patients whose type 2 diabetes mellitus is inadequately controlled with metformin. Diabetes Obes Metab (2014) 0.89
Comparison of in-vitro outcomes from cryopreserved oocytes and sibling fresh oocytes. Reprod Biomed Online (2006) 0.89
Enzastaurin inhibits tumours sensitive and resistant to anti-EGFR drugs. Br J Cancer (2008) 0.89
Dipeptidyl peptidase 4 (DPP-4) inhibitors and their role in Type 2 diabetes management. J Endocrinol Invest (2007) 0.89
Regulation of medical devices used in diabetology in Europe: time for reform? Diabetologia (2012) 0.89
PPARG2 Pro12Ala and ADAMTS9 rs4607103 as "insulin resistance loci" and "insulin secretion loci" in Italian individuals. The GENFIEV study and the Verona Newly Diagnosed Type 2 Diabetes Study (VNDS) 4. Acta Diabetol (2012) 0.88
High blood ketone body concentration in type 2 non-insulin dependent diabetic patients. J Endocrinol Invest (1996) 0.88
Preprandial combination of lispro and NPH insulin improves overall blood glucose control in type 1 diabetic patients: a multicenter randomized crossover trial. Nutr Metab Cardiovasc Dis (2001) 0.88
Blood pressure, serum cholesterol and nutritional state in Tanzania and in the Amazon: comparison with an Italian population. J Hypertens (1997) 0.87
Forearm nitric oxide balance, vascular relaxation, and glucose metabolism in NIDDM patients. Diabetes (1997) 0.87
Microalbuminuria and transcapillary albumin leakage in essential hypertension. Hypertension (1999) 0.86
Enhanced responsiveness of blood pressure to sodium intake and to angiotensin II is associated with insulin resistance in IDDM patients with microalbuminuria. Diabetes (1998) 0.86
Efficacy and safety of vildagliptin in patients with type 2 diabetes mellitus inadequately controlled with dual combination of metformin and sulphonylurea. Diabetes Obes Metab (2013) 0.86
Long-term safety and efficacy of linagliptin as monotherapy or in combination with other oral glucose-lowering agents in 2121 subjects with type 2 diabetes: up to 2 years exposure in 24-week phase III trials followed by a 78-week open-label extension. Int J Clin Pract (2012) 0.86
Hyperglucagonemia and insulin-mediated glucose metabolism. J Clin Invest (1987) 0.86
Preparation and evaluation of nanoparticles made of chitosan or N-trimethyl chitosan and a cisplatin-alginate complex. J Control Release (2007) 0.86
Increased transcapillary escape rate of albumin in microalbuminuric type II diabetic patients. Diabetes Care (1995) 0.86
Plasma and fibroblasts of Tangier disease patients are disturbed in transferring phospholipids onto apolipoprotein A-I. J Lipid Res (1998) 0.85
Vandetanib: An overview of its clinical development in NSCLC and other tumors. Drugs Today (Barc) (2010) 0.85
Neoadjuvant FOLFIRI+bevacizumab in patients with resectable liver metastases from colorectal cancer: a phase 2 trial. Br J Cancer (2013) 0.85
Effects of exendin-4 on islets from type 2 diabetes patients. Diabetes Obes Metab (2008) 0.85